# A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284

> **NCT06884098** · PHASE1 · RECRUITING · sponsor: **Addpharma Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Primary Hypercholesterolaemia

## Interventions

- **DRUG:** AD-228B
- **DRUG:** AD-2284

## Key facts

- **NCT ID:** NCT06884098
- **Lead sponsor:** Addpharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-10
- **Primary completion:** 2025-04
- **Final completion:** 2025-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06884098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06884098, "A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06884098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*